Is 1466.HK overvalued or undervalued?

1466.HK currently has a P/E ratio of -30.30. Relative to the sector average of 8.90, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Baijin Life Science Holdings Limited stock?

Baijin Life Science Holdings Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 1466.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 1466.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 1466.HK to protect their purchasing power. Because 1466.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 1466.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 1466.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 1466.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks1466.HK

Baijin Life Science Holdings Limited

HK$1.70+HK$0.00+0.00%

HKSE / HKD

Market cap

HK$1.6B

P/E

-30.3

EPS (TTM)

HK$-0.01

Dividend yield

0.00%

Beta

-0.31

1Y return

+220.75%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$8M2022

$11M2023

$7M2024

$17M2025

$11M2026

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.15Low
Current ratio2.97
Cash ratio0.67
Net margin-42.4%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

1466.HK-30.3
Consumer Cyclical sector median8.9
S&P 50022.0

Trades about 440% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.00
Price to book8.26
EPS (TTM)HK$-0.01
Payout ratio0%
FCF yield-4.53%

Range & risk

HK$0.47HK$1.96

Trading in the upper third of its 52-week band

Beta-0.31

Profile

What Baijin Life Science Holdings Limited actually does

Affluent Partners Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisition, processing, design, manufacturing, assembly, trading, and wholesale distribution. The company's activities are structured into two distinct divisions: the sale of pearl and jewelry items, and strategic investment alongside financial services. Additionally, it allocates capital to financial assets within the real estate sector. Affluent Partners operates internationally, with a footprint in Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China. This enterprise was previously known as Man Sang Jewellery Holdings Limited, undergoing a name change to Affluent Partners Holdings Limited in February 2017.

CEO

Sze Ming Cheung

Employees

Headquarters

Hong Kong

Founded

2014-10-17

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 1466.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

1466.HK has a beta of -0.31, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Baijin Life Science Holdings Limited